The pharmaceutical industry is experiencing an unprecedented manufacturing expansion that demands equally sophisticated compliance infrastructure. As major drug manufacturers commit over $300 billion to new production facilities worldwide, the implications for quality management systems extend far beyond the pharmaceutical sector into cannabis, CBD, nutraceuticals, and other highly regulated industries. The Catalyst: When Supply Chain Vulnerabilities […]